Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQ-AI Regulatory News (IQAI)

  • There is currently no data for IQAI

Purchase of Assets

30 Mar 2012 07:54

RNS Number : 4345A
MBL Group PLC
30 March 2012
 



 



30 MARCH 2012

 

 

MBL Group plc

("MBL" or the "Group")

 

 

PURCHASE OF TRADE AND ASSETS OF LISTEN2, GARDEN BIRD SUPPLIES AND GARDEN CENTRE ONLINE

 

MBL Group plc, the UK distributor of home entertainment products, is pleased to announce that it has conditionally agreed to purchase the trade and certain assets of Listen2 ("L2"), Garden Bird Supplies ("GBS") and Garden Centre Online ("GCO") from Flying Brands Limited for a total cash consideration of £0.72m on completion.

 

Following the loss of its major customer in April 2011, the Board determined that it was no longer financially viable to continue to supply direct to major retailers and the strategic decision was made to continue the transition towards direct to consumer and online sales and seek opportunities to diversify operations. The Board of MBL consider that the purchase represents complementary additions to the Group's existing operations which build on the Board's strategic plan.

 

Listen2 is a direct mail order catalogue and telephone-based retail business which specialises in the home entertainment market.

 

Garden Bird Suppliesis an established direct mail order, online and telephone-based retail business which specialises in the sale of garden bird seed and associated products.

 

Garden Centre Onlineis an online and telephone-based retail business which specialises in the sale of garden and outdoor leisure equipment.

 

L2, GBS and GCO have an established customer base which it is anticipated will enhance the current offering of the Group. For the year ending 31 December 2010, the businesses generated an operating profit of £0.6m.

 

The purchase is conditional on Flying Brands Limited receiving shareholder approval for the disposals and it is expected that completion will take place no later than 4 May 2012.

 

Peter Cowgill, Chairman of MBL, commented:

 

"I am very pleased to announce the purchase of Listen2, Garden Bird Supplies and Garden Center Online. The purchase broadens the scope of the Group's operations and supports the Board's strategic intent to strengthen the Group following the loss of its major customer last year,"

 

 

END

 

 

 

 

 

MBL GROUP PLC

Tel: 0161 767 1620

Peter Cowgill, Chairman

BISHOPSGATE COMMUNICATIONS LIMITED

Tel: 020 7562 3350

Deepali Schneider

mbl@bishopsgatecommunications.com

N+1 BREWIN (NOMAD and BROKER)

Tel: 020 3201 3710

Robert Beenstock

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCURVNRURAOORR
Date   Source Headline
27th May 20257:00 amRNSChange of Name
22nd May 20252:23 pmRNSResult of AGM
2nd May 20257:29 amRNSApplication: FDA Breakthrough Therapy Designation
29th Apr 202510:49 amRNSNotice of AGM
25th Apr 20251:46 pmRNSPublication of Annual Report
11th Apr 20253:32 pmRNSPromising Preliminary Results of Phase 1 Study
18th Mar 202510:38 amRNSPlacing to raise £250,000
3rd Feb 20257:00 amRNSIB Expands Distribution with Blackford
22nd Jan 20257:00 amRNSOperations Update
10th Jan 20257:49 amRNSIB and Prism Secure First Installation
20th Nov 20247:00 amRNSImaging Biometrics Expands Distribution
19th Nov 202411:27 amRNSBoard Changes
5th Nov 20247:00 amRNSNew Patent Application and Trading Update
15th Oct 202410:28 amRNSHolding(s) in Company
14th Oct 202412:08 pmRNSHolding(s) in Company
14th Oct 202412:05 pmRNSPDMR dealing and TR1 announcement
11th Oct 202410:42 amRNSAcquisition of Interest by Braveheart
25th Jun 20249:59 amRNSIB Opens Expanded Access Program
14th Jun 20248:38 amRNSClinical Trial Updates
29th May 20243:08 pmRNSResult of AGM
23rd May 20247:00 amRNSMajor East Coast Health System Chooses IB Nimble
20th May 20247:10 amRNSSecond FDA Rare Pediatric Disease Designation
17th May 20247:00 amRNSIB Software Enhances Clinical Decision-Making
10th May 20248:15 amRNSRare Pediatric Disease Designation Granted to GaM
2nd May 202412:47 pmRNSIB Announces Expanded Access Program for GaM
29th Apr 20243:26 pmRNSPublication of Annual Report
5th Mar 20247:00 amRNSGrant of Options
1st Mar 20248:22 amRNSHolding(s) in Company
1st Mar 20248:20 amRNSHolding(s) in Company
26th Feb 20247:00 amRNSResult of Broker Option and Total Voting Rights
22nd Feb 20247:00 amRNSPlacing and Broker Option
9th Feb 202412:49 pmRNSFDA Application Update
2nd Feb 20248:39 amRNSIB awarded a $100,000 grant
22nd Jan 202410:05 amRNSHolding(s) in Company
15th Jan 20247:01 amRNSDirector Dealings and Conversion of CLNs
15th Jan 20247:00 amRNSHolding(s) in Company
10th Jan 20247:00 amRNSIB Launching an Expanded Access Program for GaM
19th Dec 20232:29 pmRNSImaging Biometrics granted FDA “Fast-Track”
5th Dec 202310:58 amRNSIQ-AI Announces Positive Interim Phase 1 Results
20th Nov 20231:42 pmRNSHolding(s) in Company
9th Nov 202311:38 amRNSDirector Dealing and Conversion of CLNs
8th Nov 202310:59 amRNSApplication for Pediatric Rare Disease Designation
6th Nov 20231:02 pmRNSHolding(s) in Company
18th Oct 20232:29 pmRNSUpdate Regarding Imaging Biometrics LLC
13th Oct 20238:55 amRNSIB Letter to Shareholders
9th Oct 20237:00 amRNSOrphan Drug Status to GaM and Total Voting Rights
3rd Oct 202311:30 amRNSHolding(s) in Company
19th Sep 20232:32 pmRNSIQ-AI shares cease trading on the OTCQB
8th Sep 20237:00 amRNSReduced Gadolinium Approach Validated'
18th Aug 202312:06 pmRNSUpdate on Collaboration Agreement with Mayo Clinic

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.